We serve Chemical Name:2,6-Dichloro-4-methylbenzoic acid CAS:99520-05-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,6-Dichloro-4-methylbenzoic acid
CAS.NO:99520-05-5
Synonyms:2,6-Dichloro-4-methylbenzoic acid
Molecular Formula:C8H6Cl2O2
Molecular Weight:205.03800
HS Code:2916399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:37.30000
Exact Mass:203.97400
LogP:3.00000
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2,6-Dichloro-4-methylbenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-Dichloro-4-methylbenzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6-Dichloro-4-methylbenzoic acid Use and application,2,6-Dichloro-4-methylbenzoic acid technical grade,usp/ep/jp grade.
Related News: In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. 2,6-Dichloro-4-methylbenzoic acid manufacturer Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. 2,6-Dichloro-4-methylbenzoic acid supplier In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. 2,6-Dichloro-4-methylbenzoic acid vendor “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.” 2,6-Dichloro-4-methylbenzoic acid factory “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.”
